← Back to Search

Transcranial Magnetic Stimulation

MagStim Rapid2 Transcranial Magnetic Simulation for Functional Neurological Disorder

N/A
Waitlist Available
Led By Bruce Bolster, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour: immediately prior to and following one session of rtms
Awards & highlights

Study Summary

This trial is testing a new way to treat patients with Functional Neurological Disorders by measuring their brain activity and timing of movements.

Eligible Conditions
  • Functional Neurological Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour: immediately prior to and following one session of rtms
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 hour: immediately prior to and following one session of rtms for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in relative timing of intention-to-act vs action production
Change in resting state activity in temporal-parietal junction brain region
Secondary outcome measures
Change in brain activity related to 'intention to act'
Change in brain activity related to motor production

Trial Design

1Treatment groups
Experimental Treatment
Group I: Repetitive Transcranial Magnetic Stimulation (rTMS)Experimental Treatment1 Intervention
1 session (3,000 pulses) of high-frequency (10Hz) repetitive stimulation applied over the right temporal parietal junction (TPJ) gyrus in individuals with Functional Neurological Disorder using a MagStim Rapid2 Transcranial Magnetic Simulation machine.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MagStim Rapid2 Transcranial Magnetic Simulation
2022
N/A
~30

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,503 Total Patients Enrolled
University of WinnipegUNKNOWN
Bruce Bolster, PhDPrincipal InvestigatorUniversity of Winnipeg

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings for participation in this trial?

"As stated on clinicaltrials.gov, the recruitment phase of this medical trial has been concluded as it was last updated on October 1st 2021 after being posted November 1st 2021. Nonetheless, 142 other studies are presently recruiting patients across different regions."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Behavioural and Electrophysiological Effects of rTMS in Functional Neurological Disorders
2022. "Behavioural and Electrophysiological Effects of rTMS in Functional Neurological Disorders". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04942600.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top